ConnectiveRx Company Profile

Background

Overview

ConnectiveRx is a technology-enabled biopharmaceutical services company specializing in patient and provider support, access, and adherence solutions for specialty and branded medications. Established in 2015, the company is headquartered in Whippany, New Jersey, with additional campuses in Pittsburgh, Pennsylvania, and other locations across the United States. ConnectiveRx partners with over 150 pharmaceutical manufacturers, serving hundreds of drug brands at various stages of the product lifecycle.

Mission and Vision

The company's mission is to simplify the prescription process by removing barriers that make it difficult for patients to access and adhere to their prescribed therapies. By integrating innovative technology with human empathy, ConnectiveRx aims to enhance patient outcomes and improve the overall healthcare experience.

Industry Significance

ConnectiveRx plays a pivotal role in the pharmaceutical services industry by bridging the gap between patients, healthcare providers, and pharmaceutical manufacturers. Its comprehensive suite of services addresses critical challenges in medication access, affordability, and adherence, thereby contributing to better health outcomes and more efficient healthcare delivery.

Key Strategic Focus

Core Objectives

• Enhancing Medication Access: Streamlining the process for patients to obtain prescribed therapies, particularly specialty medications.

• Improving Adherence: Implementing solutions that support patients in following their prescribed treatment regimens.

• Affordability Solutions: Providing programs that reduce out-of-pocket costs for patients, making medications more accessible.

Areas of Specialization

• Hub Services: Offering centralized support for patients and healthcare providers to navigate the complexities of specialty medications.

• Patient Support Programs: Delivering personalized assistance to patients to enhance engagement and adherence.

• Affordability Programs: Implementing initiatives that help patients manage the financial aspects of their healthcare.

Key Technologies Utilized

• Electronic Health Record (EHR) Integrations: Embedding support services directly into healthcare providers' workflows to facilitate seamless patient care.

• Mobile Platforms: Developing applications that provide patients with easy access to support resources and medication information.

• Data Analytics: Utilizing analytics to personalize patient support and improve program outcomes.

Primary Markets Targeted

• Pharmaceutical Manufacturers: Collaborating to enhance patient engagement and medication adherence for their products.

• Healthcare Providers: Supporting physicians, nurse practitioners, and physician assistants in delivering comprehensive patient care.

• Patients: Focusing on individuals requiring specialty and branded medications, particularly those managing chronic conditions.

Financials and Funding

Funding History

ConnectiveRx has undergone several funding rounds to support its growth and expansion:

• 2015: Genstar Capital invested in ConnectiveRx, facilitating the company's formation and initial growth.

• 2017: The acquisition of Careform enhanced ConnectiveRx's hub services capabilities.

• 2018: The acquisition of The Macaluso Group expanded the company's reimbursement and payment solutions.

• 2020: A recapitalization led by Genstar Capital, with participation from Harvest Partners SCF and Blackstone Tactical Opportunities, provided enhanced financial flexibility.

Total Funds Raised

While specific figures for total funds raised are not publicly disclosed, the strategic investments and acquisitions indicate substantial financial backing to support ConnectiveRx's operations and growth initiatives.

Notable Investors

• Genstar Capital: A leading private equity firm specializing in investments in targeted segments of the financial services, healthcare, industrial, and software industries.

• Harvest Partners SCF: A private equity firm focusing on providing capital solutions to middle-market companies.

• Blackstone Tactical Opportunities: An investment platform within Blackstone that seeks to identify and execute on attractive, differentiated investment opportunities.

Utilization of Capital

The capital raised has been utilized for:

• Acquisitions: Enhancing service offerings and expanding capabilities through strategic acquisitions.

• Technology Development: Investing in technological infrastructure to improve patient support and provider engagement.

• Operational Expansion: Supporting the growth of the company's workforce and operational facilities to meet increasing demand.

Pipeline Development

Key Pipeline Candidates

ConnectiveRx's pipeline focuses on:

• Hub Services Expansion: Enhancing centralized support platforms for patients and healthcare providers.

• Patient Support Programs: Developing personalized assistance programs to improve patient engagement and adherence.

• Affordability Initiatives: Implementing programs to reduce out-of-pocket costs for patients.

Stages of Development

The company is in the implementation and scaling stages for these initiatives, integrating them into existing services and expanding their reach.

Target Conditions

The focus is on chronic conditions requiring specialty and branded medications, including cardiovascular diseases, diabetes, and oncology.

Anticipated Milestones

• Short-Term: Integration of new services into existing platforms.

• Medium-Term: Expansion of patient enrollment in support programs.

• Long-Term: Demonstration of improved patient outcomes and adherence rates.

Technological Platform and Innovation

Proprietary Technologies

• BrandHub Platform: A proprietary platform that delivers inventory management, EHR integration, and therapy cycle management to enhance product access.

Significant Scientific Methods

• Data Analytics: Utilizing data-driven insights to personalize patient support and improve program outcomes.

• EHR Integration: Embedding support services directly into healthcare providers' workflows to facilitate seamless patient care.

AI-Driven Capabilities

• Personalization Engine: Employing AI to tailor patient support programs, enhancing engagement and adherence.

Leadership Team

Executive Profiles

• Jim Corrigan: Chief Executive Officer. With a background in medical devices and strategy, Jim leads ConnectiveRx with a focus on simplifying the medication journey for patients.

• Jim Mahon: Chief Development Officer. Jim oversees the company's development strategies, driving growth and innovation.

• Chris Breakiron: Chief Financial Officer. Chris manages the financial operations, ensuring fiscal responsibility and strategic investment.

• Frank Dana: President and Chief Commercial Officer. Frank leads commercial strategies, focusing on market expansion and customer engagement.

• Dan Torrens: Chief Operating Officer. Dan oversees daily operations, ensuring efficient service delivery and operational excellence.

Competitor Profile

Market Insights and Dynamics

The pharmaceutical services industry is experiencing growth due to increasing demand for specialty medications and the need for enhanced patient support services. Companies like ConnectiveRx are well-positioned to capitalize on this trend by offering comprehensive solutions that address medication access, affordability, and adherence.

Competitor Analysis

• GoodRx: Provides prescription price comparison and discount services, focusing on affordability.

• Livongo: Offers digital health solutions for chronic condition management, emphasizing patient engagement.

• OptimizeRx: Delivers digital health messaging solutions to improve patient outcomes.

Strategic Collaborations and Partnerships

• Veradigm Partnership: Entered into a long-term strategic partnership to deliver point-of-care prescription-related messages to patients.

• HelpAround Investment: Strategic investment to enhance mobile access for patients managing specialty medications.

• RxLink Collaboration: Partnered to expand patient medication affordability by providing real-time savings options.

Operational Insights

ConnectiveRx differentiates itself through its integrated approach, combining proprietary technology with hands-on services to guide patients through the medication access process. This holistic strategy enables the company to effectively address the complexities of the healthcare system, providing a seamless experience for patients and healthcare providers.

Strategic Opportunities and Future Directions

The company is well-positioned to expand its services by leveraging its technological infrastructure and strategic partnerships. Opportunities include:

• Expanding EHR Integrations: Enhancing the reach of support services through deeper integration with healthcare providers' systems.

• Developing Mobile Solutions: Creating mobile applications to provide patients with easy access to support resources and medication information.